Enfusion Inc
NYSE:ENFN
Enfusion Inc
NYSE:ENFN
Price:
9.31 USD
-2%
Market Closed
Updated:
May 1, 2024
P/S
Price to Sales
Price to Sales
4.8
Current
5.9
Median
2.3
Industry
Lower
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=4.8
Market Cap
/
836.7m
Revenue
174.5m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| US |
|
Enfusion Inc
NYSE:ENFN
|
836.7m USD | 4.8 | |
| US |
|
Ezenia! Inc
OTC:EZEN
|
789.1B USD | 325 533 | |
| US |
A
|
Advant-e Corp
OTC:ADVC
|
670.7B USD | 66 369.3 | |
| US |
|
Salesforce Inc
NYSE:CRM
|
261.1B USD | 7.5 | |
| US |
|
Adobe Inc
NASDAQ:ADBE
|
209.7B USD | 10.5 | |
| DE |
|
SAP SE
XETRA:SAP
|
198.1B EUR | 6.3 | |
| US |
|
Intuit Inc
NASDAQ:INTU
|
175.2B USD | 11.6 | |
| US |
|
Synopsys Inc
NASDAQ:SNPS
|
80.9B USD | 13.2 | |
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
74.9B USD | 18.4 | |
| US |
|
Workday Inc
NASDAQ:WDAY
|
64.6B USD | 8.9 | |
| CA |
|
Constellation Software Inc
TSX:CSU
|
75.1B CAD | 6.5 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
4
2-Years Forward
P/S
3.4
3-Years Forward
P/S
2.9
You don't have any saved screeners yet
